Psychiatry and Psychedelic Assisted Therapy

Psychedelic medicine and Psychedelic Assisted Therapy comprise an emerging field with tremendous therapeutic potential, quickly gaining recognition as cutting edge, powerful, and safe options for treatment-resistant psychiatric disorders. In light of this novel emerging evidence, Wayfound is committed to investigate, research and deploy new approaches for patients experiencing treatment-resistant conditions.


Individual and Group Programs

Wayfound is currently assessing patients for suitability for ketamine therapy, particularly for patients with treatment resistant depression or PTSD. Psychiatric assessment for ketamine therapy will be offered upon physician referral. Please contact Wayfound for details.